Recently, two studies reported an association of FOXA2 heterozygous mutations with hyperinsulinism, hypoglycemia, pituitary hormone deficiency, craniofacial, and endoderm‐derived organ abnormalities (Giri et al., 2017; Vajravelu et al., 2018). This evidence concerns the gene FOXA2 and hyperinsulinism.